Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Cameron McKendryTurtle Creek | Food ProductsFood Products | Turtle Creek Fund - PBH.TO Another large detractor from our performance in 2026 is Premium Brands, a company that we have owned for over 20 years (at various weightings) and is currently one of our largest holdings. Premium Brands is... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Luke CummingsHarvest Lane Asset Management | Casinos & GamingHotels, Restaurants & Leisure | Long PBH.AX (Pointsbet) Pointsbet was a highly rewarding arbitrage trade that spanned several months in 2025, characterized by multiple competing bidders. The transaction transitioned... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Steve JohnsonForager Australian Shares Fund | Casinos & GamingHotels, Restaurants & Leisure | Long PBH.AX (PointsBet Holdings Limited) PointsBet received multiple acquisition proposals from MIXI and BlueBet. Forager sees strategic... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Brandes Investment Partners, L.P.Brandes Small Cap Value Fund | PharmaceuticalsPharmaceuticals | Brandes Small Cap Value Fund 2025 Q3 (PBH) Brandes re-entered Prestige Consumer Healthcare after share weakness created a value opportunity. Prestige owns market-leading... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Andrew J. FlemingHeartland Value Plus Fund | PharmaceuticalsPharmaceuticals | Heartland Value Plus Fund 2025 Q3 (PBH) Prestige Consumer Healthcare (PBH) — the company behind familiar over-the-counter medical products such as Dramamine, Luden's cough drops, and Clear Eyes eye drops — was the biggest detractor to our Strategy's performance during the quarter. That's in part... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | John W. RogersAriel Appreciation Fund | PharmaceuticalsPharmaceuticals | Ariel Appreciation Fund 2025 Q3 (PBH) Prestige Consumer Healthcare Inc. (PBH), a marketer and distributor of over-the-counter pharmaceutical products. The company has... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Ariel Investments, LLCAriel Focus Fund | PharmaceuticalsPharmaceuticals | Ariel Focus Fund 2025 Q3 (PBH) New holding and distributor of over-the-counter pharmaceutical drugs and products, Prestige Consumer Healthcare Inc. (PBH), also declined following mixed earnings results and a downward revision to full-year guidance. Sales were impacted... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.